IL4 and breast cancer: Age above ≥50 years [12, 25], post-menopausal status [12], cytogenetic alterations [32], higher (IL-4, IL-12) and lower (IL-18) levels of interleukins [11], and breast cancer history [37], were occasionally found to be significantly associated with +p53-AAbs.